Opioid use disorder is a medical condition that can affect the brain, body, relationships, work, and safety. Treatment is not limited to stopping opioid use for a few days. Effective care can include medication, withdrawal support, counseling, recovery services, overdose prevention, and ongoing follow-up.
Recovery can look different from one person to another. Some people begin in a hospital or withdrawal-management setting. Others start medication through an outpatient clinician or an opioid treatment program. The appropriate starting point depends on current opioid use, withdrawal risk, overdose history, other health conditions, mental health needs, housing, support, and access to care.
If someone may be experiencing an opioid overdose, call 911 and give naloxone if it is available. Stay with the person until emergency help arrives. Signs can include inability to wake, very slow or stopped breathing, choking or gurgling sounds, discolored lips or nails, and pinpoint pupils.
SAMHSA National Helpline: 1-800-662-4357
988 Suicide & Crisis Lifeline: call or text 988
FindTreatment.gov can help locate treatment programs.
What Opioid Addiction Treatment Addresses
Opioid addiction treatment addresses more than physical dependence. Physical dependence means the body has adapted to an opioid and may develop withdrawal symptoms when use stops or decreases. Opioid use disorder involves a pattern of opioid use that causes clinically significant problems or distress.
A complete assessment may review:
- Which opioids are being used and how they are taken
- Recent use and expected withdrawal
- Past overdoses and naloxone access
- Previous treatment and medication experiences
- Medical conditions, pregnancy, pain, and current prescriptions
- Depression, anxiety, trauma, psychosis, or suicidal thoughts
- Alcohol, benzodiazepine, stimulant, or other substance use
- Housing, transportation, family support, legal concerns, and work
- Goals, preferences, and barriers to continuing care
This information helps a provider recommend a level of care and a treatment plan. The plan may change as safety, symptoms, and daily stability change.
Medications for Opioid Use Disorder
The FDA has approved three medications for opioid use disorder: buprenorphine, methadone, and naltrexone. These medications are not interchangeable, and each has different requirements, benefits, limitations, and safety considerations.
Buprenorphine
Buprenorphine reduces withdrawal symptoms and cravings by partially activating opioid receptors. It is available in several formulations, including products used under the tongue or inside the cheek and extended-release injections.
Treatment usually begins after an assessment of recent opioid use and withdrawal risk. Starting too soon after some opioids can trigger sudden withdrawal, so initiation should follow a qualified clinician’s instructions. Buprenorphine can be prescribed in office-based and other authorized settings, which can make ongoing care more accessible for some people.
Methadone
Methadone is a full opioid agonist used to reduce withdrawal and cravings and support stability. For opioid use disorder, it is generally provided through a federally certified opioid treatment program, subject to applicable federal and state requirements.
Opioid treatment programs can provide medication along with counseling, medical services, drug testing, and recovery support. Visit frequency and take-home medication arrangements depend on program rules, clinical assessment, and current regulations.
Naltrexone
Naltrexone blocks opioid receptors rather than activating them. It is available as an oral medication and as an extended-release injection. A person must be opioid-free for a sufficient period before starting it, because beginning naltrexone while opioids remain in the body can precipitate withdrawal.
Naltrexone does not reduce withdrawal during the initial opioid-free period. A clinician should evaluate whether it fits the person’s goals, health, recent opioid use, and ability to complete that period safely.
Medication Is Treatment, Not a Substitute for Recovery
Methadone and buprenorphine are sometimes wrongly described as replacing one addiction with another. When used as prescribed for opioid use disorder, they are evidence-based medical treatments. They can reduce withdrawal and cravings and help people remain engaged in care.
Treatment should not be judged only by whether a person is taking medication. Recovery may also involve safer housing, improved health, fewer overdoses, repaired relationships, work or school stability, reduced illegal activity, and progress toward personally meaningful goals.
Medication duration should be individualized. SAMHSA states that medications for opioid use disorder may be used for months, years, or longer. Stopping medication should be discussed with the treating clinician. Abrupt discontinuation can increase withdrawal, return-to-use, and overdose risk.
Withdrawal Management and Detox
Opioid withdrawal can be intensely uncomfortable and may include muscle aches, sweating, restlessness, nausea, vomiting, diarrhea, anxiety, insomnia, and strong cravings. It is generally not described as life-threatening by itself in otherwise healthy adults, but complications such as dehydration, co-occurring illness, pregnancy-related concerns, or use of other substances can create serious risks.
Withdrawal management can include medical assessment, symptom monitoring, hydration support, medications, and planning for ongoing treatment. Detox alone does not treat the full opioid use disorder. Without continuing medication or other follow-up care, tolerance may fall. Returning to a previously used amount can then increase overdose risk.
People using opioids along with alcohol or benzodiazepines need careful evaluation. Alcohol and benzodiazepine withdrawal can become medically dangerous, and combining sedating substances can increase overdose risk. Do not attempt an unsupervised taper based on general internet instructions.
Residential, Inpatient, and Outpatient Care
Medication treatment can occur across several settings.
Outpatient Care
Outpatient treatment may include medication visits, counseling, peer support, case management, and mental health care while the person continues living at home. Frequency can range from standard appointments to intensive outpatient or partial hospitalization schedules.
Outpatient care can work well when medical and psychiatric risks are manageable and the person has enough stability between visits. The plan should include what to do if symptoms, cravings, housing, or safety worsen.
Residential Treatment
Residential programs provide a structured living environment. They may be useful when a person needs more daily support, has an unstable recovery environment, or has not been able to remain safe in a less structured setting.
Not every residential program offers all medications for opioid use disorder. Before admission, ask whether the program continues existing medication, can initiate medication, works with an outside prescriber, and provides overdose-prevention planning at discharge.
Hospital or Medically Managed Care
Hospital-level care may be needed for severe medical illness, overdose complications, serious psychiatric symptoms, pregnancy-related concerns, dangerous withdrawal from another substance, or other acute risks. A hospital stay may stabilize an immediate crisis, but discharge planning should connect the person to continuing opioid use disorder treatment.
Counseling and Recovery Support
Medication can be combined with counseling and other support, but access to medication should not be withheld solely because counseling is unavailable or a person is not ready for a particular therapy format.
Useful services may include:
- Motivational counseling
- Cognitive behavioral approaches
- Contingency management where available
- Trauma-informed mental health care
- Family education with the person’s permission
- Peer recovery support
- Housing, transportation, employment, and legal assistance
- Pain-care coordination
- HIV, hepatitis, and primary-care services
The best combination depends on the person’s needs and preferences. Treatment should avoid shame, punishment, and automatic discharge after a return to use. A return to opioid use is a signal to reassess safety, medication, support, and level of care.
Overdose Prevention Is Part of Treatment
Naloxone can reverse an opioid overdose when given in time. The CDC advises giving naloxone if available, calling 911, trying to keep the person awake and breathing, placing the person on their side to reduce choking risk, and staying until emergency help arrives.
People in treatment and those close to them should know where naloxone is stored and how to use it. Naloxone is available over the counter in the United States. More than one dose may be needed in some overdoses, but emergency services should still be called because symptoms can return or another medical problem may be present.
Overdose risk can increase after a period of reduced or stopped opioid use because tolerance decreases. High-risk transitions can include leaving detox, residential treatment, hospitalization, jail, or prison. A discharge plan should address medication continuity, naloxone, follow-up appointments, transportation, and what to do if a dose or visit is missed.
Choosing a Treatment Program
Ask direct questions before enrolling:
- Does the program offer or continue buprenorphine, methadone, or naltrexone?
- If methadone is needed, is the program a certified opioid treatment program or connected to one?
- How are overdose risk and naloxone addressed?
- What happens if opioid use occurs during treatment?
- Are mental health and other substance-use conditions assessed?
- How are medications managed during residential care or hospitalization?
- What services are available after discharge?
- Does the program accept the person’s insurance, Medicaid, or Medicare?
- Are there transportation, telehealth, or pharmacy barriers?
- How quickly can treatment begin?
Be cautious of programs that promise a cure, require medication discontinuation without individualized assessment, shame people for recurrence of symptoms, or claim one approach works for everyone.
Building a Continuing Recovery Plan
Recovery support should continue after the first phase of treatment. A practical plan may include:
- A scheduled medication appointment before discharge
- Enough medication or a confirmed dosing plan to prevent an interruption
- Naloxone for the person and household
- A crisis and overdose response plan
- Counseling or peer-support options
- Primary and mental health care
- Safe housing and transportation
- A plan for pain, surgery, or emergency medical care
- Contact information for the treatment team
- Clear steps if cravings, withdrawal, or return to use occurs
Progress is not always linear. The goal is to keep the person connected to effective care and reduce the chance that a setback becomes a fatal overdose.
Frequently Asked Questions
Is methadone or buprenorphine replacing one drug with another?
No. When taken as prescribed for opioid use disorder, methadone and buprenorphine are evidence-based treatments. They are used in controlled doses to reduce withdrawal and cravings and support stability.
Do I have to go through detox before starting treatment?
Not always. Buprenorphine and methadone can be part of withdrawal management and ongoing treatment. Naltrexone requires an opioid-free period. A clinician should determine the safest sequence based on recent use and health.
How long should medication treatment last?
There is no single correct duration. Some people use medication for months, years, or longer. Decisions to reduce or stop medication should be individualized and planned with the treating clinician.
What if opioid use happens during treatment?
Tell the treatment team. The response should focus on overdose safety and reassessment rather than shame. The medication dose, treatment intensity, other substance use, mental health, and recovery environment may need review.
Where can I find opioid treatment?
Use FindTreatment.gov, SAMHSA’s Opioid Treatment Program Directory, a healthcare professional, a community health center, or a state substance-use agency. In an overdose or immediate danger, call 911.
Sources
U.S. Food and Drug Administration, “Information about Medications for Opioid Use Disorder.”
https://www.fda.gov/drugs/food-and-drug-administration-overdose-prevention-framework/information-about-medications-opioid-use-disorder-moudSubstance Abuse and Mental Health Services Administration, “TIP 63: Medications for Opioid Use Disorder.”
https://www.samhsa.gov/resource/ebp/tip-63-medications-opioid-use-disorderSubstance Abuse and Mental Health Services Administration, “Provider Information on Treatment Options.”
https://www.samhsa.gov/medications-substance-use-disorders/medications-counseling-related-conditions/Substance Abuse and Mental Health Services Administration, “Substance Use Disorder Treatment.”
https://www.samhsa.gov/substance-use/treatmentSubstance Abuse and Mental Health Services Administration, “Opioid Treatment Program Information for Providers.”
https://www.samhsa.gov/substance-use/treatment/opioid-treatment-programCenters for Disease Control and Prevention, “What to Do If You Think Someone Is Overdosing.”
https://www.cdc.gov/stop-overdose/response/index.htmlCenters for Disease Control and Prevention, “Naloxone Frequently Asked Questions.”
https://www.cdc.gov/stop-overdose/naloxone-faq/index.htmlCenters for Disease Control and Prevention, “Preventing Opioid Overdose.”
https://www.cdc.gov/overdose-prevention/prevention/
This article provides general educational information only and is not medical advice, diagnosis, or treatment. Always seek the guidance of a qualified health provider with questions about substance use, withdrawal, or mental health. If someone may be overdosing — unresponsive, not breathing, blue lips — call 911 immediately.